By Barry Cohen, Executive Director, National Algae Association The DoE has spent $2.5 billion on algae research but to date nothing has been commercialized. Why? Because their mission is to develop technologies. It’s not their problem or concern what happens to them – they just continue to develop them! We need your help! We need […]
Speciality chems giant opts for the OPX Biotechnologies’ EDGE technology to slash development timelines and costs, and boost ROI. Making biobased work on price and performance. In Germany and Colorado, Evonik and OPX Biotechnologies have entered into an agreement to jointly develop a list of (undisclosed) bio-based specialty chemicals. Evonik is one of the world […]
Also, next-gen waste-to-biofuels biofuels pioneer expects to reach commissioning stage by summer at first commercial plant In Canada, Enerkem announced that the Canadian government will contribute $1.1 million to a project developing new catalytic processes for the conversion of waste into “drop-in” biofuels. These “drop-in” biofuels are fully interchangeable with hydrocarbon fuels, such as conventional […]
One thing to remember about Shell – it’s not your Dad’s oil company. In an exclusive Digest interview, Shell’s VP for Alternative Energy, Matthew Tipper, reveals the company’s thinking about RFS2, their increasing re-focus on North America and the EU. Plus, Shell’s ambition to “build, own and operate” a global biofuels business “to complement what […]
World’s #1 chemical company to produce renewable Butanediol using Genomatica’s process. The Digest has a one-on-one with Genomatica CEO Christophe Schilling to explore the deal in-depth. In Germany, BASF announced that it plans to begin production of 1,4-butanediol based on renewable feedstock (renewable BDO) using Genomatica’s patented process. The one-step fermentation process is based on […]
Biofuels’s Montagues and Capulets were at it again last week — with a flurry of press releases about court decisions and commercial timelines regarding their respective isbutanol technologies. At the heart of it — a dispute over the significance of last week’s dismissal of a lawsuit brought by Gevo against Butamax for patent infringement. Here’s […]
Raises $80M at $10 per share; becomes first new industrial biotech company to complete IPO in more than a year. What went right and how? Is the IPO window re-opening? In Minnesota, BioAmber announced the pricing of its initial public offering of 8 million units consisting of one share of common stock and one warrant […]
In Texas, KiOR announced a Q1 2013 net loss of $31.3 million, or $0.30 per share, compared to a Q1 2012 loss of $16.8 million. The company reported revenues of $71,000. “Building on the first gallons of cellulosic diesel we shipped in March, we continue to make progress with operations at our Columbus facility,” said […]
If you have been following events in California, oil refiners have been waging a well-funded war on California’s Low Carbon Fuel Standard, which requires oil companies to reduce the carbon pollution from gasoline and diesel by 10 percent by 2020. Centerpiece in their strategy was a June 2012 report from Boston Consulting Group (funded by […]
The sector’s perennial hottest company strikes again — with “potentially disruptive” new technology to change the positioning and performance of triglyceride oils. In California, Solazyme and AkzoNobel announced an agreement targeting the development of advanced tailored triglyceride oils and commercial sales for near-term product supply. The agreement focuses on supply for the chemical giant’s Surface […]
